Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes

BACKGROUND: 5-azacytidine (5-AZA) improves survival of patients with higher-risk myelodysplastic syndromes (MDSs) and oligoblastic acute myeloid leukemia (AML); however, predictive factors for response and outcome have not been consistently studied. METHODS: This study of the Hellenic MDS Study Grou...

Full description

Saved in:
Bibliographic Details
Published in:Ther Adv Hematol
Main Authors: Papageorgiou, Sotirios G., Kotsianidis, Ioannis, Bouchla, Anthi, Symeonidis, Argyris, Galanopoulos, Athanasios, Viniou, Nora-Athina, Hatzimichael, Eleftheria, Vassilakopoulos, Theodoros P., Gogos, Dimitrios, Megalakaki, Aikaterini, Zikos, Panagiotis, Diamantopoulos, Panagiotis, Kourakli, Alexandra, Giannoulia, Panagiota, Papoutselis, Menelaos, Poulakidas, Elias, Arapaki, Maria, Vardi, Anna, Anagnostopoulos, Achilles, Mparmparousi, Despoina, Papaioannou, Maria, Bouronikou, Eleni, Dimou, Maria, Papadaki, Helen, Panayiotidis, Panayiotis, Pappa, Vasiliki
Format: Artigo
Language:Inglês
Published: SAGE Publications 2020
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7727043/
https://ncbi.nlm.nih.gov/pubmed/33343854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620720966121
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items